Advertisement
Advertisement
U.S. Markets open in 3 hrs 9 mins
Advertisement
Advertisement
Advertisement
Advertisement

CBD Life Sciences Inc. (CBDL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 03:56PM EDT
Advertisement

CBD Life Sciences Inc.

10855 N 116th Street
Suite 115
Scottsdale, AZ 85259
United States
480 410 6780
https://lbcbioscienceinc.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees7

Key Executives

NameTitlePayExercisedYear Born
Ms. Lisa Anne NelsonPres, CEO, CFO & Director240kN/A1967
Ms. Vicki MartinezSec. & DirectorN/AN/AN/A
Ms. Mercedes SturmTreasurer & DirectorN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Corporate Governance

CBD Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement